DBV Technologies S.a. is based out of Montrouge. DBV Technologies SA operates as a biopharmaceutical firm. The Company develops products and immunotherapies for the diagnosis and treatment of various food allergies. DBV Technologies delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin. The firm has no submitted 13F filings and does not appear to be an investment advisor.
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
DBV Technologies S.A.177-181 AVENUE PIERRE BROSSOLETTE
MONTROUGE I0 92120
Business Phone: 33(0)155427878
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)